XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 111 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,539 | -72.5% | 116,956 | -61.3% | 0.00% | – |
| Q2 2023 | $792,172 | -36.6% | 302,356 | -60.5% | 0.00% | – |
| Q1 2023 | $1,249,000 | +991169.8% | 766,291 | +711.6% | 0.00% | – |
| Q4 2022 | $126 | -99.9% | 94,418 | +12.0% | 0.00% | – |
| Q3 2022 | $132,000 | +7.3% | 84,322 | +5.9% | 0.00% | – |
| Q2 2022 | $123,000 | +156.2% | 79,610 | +326.7% | 0.00% | – |
| Q1 2022 | $48,000 | +23.1% | 18,655 | +40.7% | 0.00% | – |
| Q4 2021 | $39,000 | – | 13,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $9,843,616 | 24.86% |
| Stonepine Capital Management, LLC | 8,640,205 | $14,083,534 | 4.72% |
| Alpine Global Management, LLC | 400,000 | $652,000 | 0.25% |
| DELTEC ASSET MANAGEMENT LLC | 622,072 | $1,013,977 | 0.25% |
| XTX Topco Ltd | 233,385 | $380,418 | 0.08% |
| Redmile Group, LLC | 1,046,587 | $1,705,937 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 316,025 | $515 | 0.05% |
| Yakira Capital Management, Inc. | 90,076 | $146,824 | 0.04% |
| IHT Wealth Management, LLC | 281,442 | $458,762 | 0.03% |
| TUDOR INVESTMENT CORP ET AL | 960,111 | $1,565 | 0.02% |